Chlorpheniramine maleate 0.4 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution — RxCUI 1053618
RxNorm drug concept · Semantic clinical drug
RxCUI 1053618
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1053618
Official nameChlorpheniramine maleate 0.4 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschlorpheniramine maleate 2 MG / psuedoephedrine hydrochloride 30 MG per 5 ML Syrup; chlorpheniramine maleate 2 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)2,000 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Chlorpheniramine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's an antihistamine used to temporarily relieve classic hay fever and allergy symptoms — things like a runny nose, sneezing, itchy or watery eyes, and an itchy throat. It works o...
- What is chlorpheniramine actually used for?
- Yes — drowsiness is one of the most common effects of chlorpheniramine, and it can be significant. Don't plan on driving or operating heavy machinery until you know how your body r...
- It's best to skip the alcohol while you're taking chlorpheniramine. Alcohol makes the drowsiness much stronger, which can be unsafe — especially if you need to drive or stay alert....
🕸️ Concept Web — How Chlorpheniramine maleate 0.4 MG/ML / pseudoephed... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Chlorpheniramine maleate 0.4 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution
RxCUI 1053618 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Chlorpheniramine
2400IN -
Pseudoephedrine
8896IN -
Chlorpheniramine / pseudoephedrine
214395MIN -
Chlorpheniramine maleate
142429PIN -
Pseudoephedrine hydrochloride
91168PIN
-
Chlorpheniramine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Chlorpheniramine / pseudoephedrine Oral Solution
371437SCDF -
Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Solution
2646526SCDFP -
Chlorpheniramine / pseudoephedrine Oral Liquid Product
1155142SCDG -
Chlorpheniramine / pseudoephedrine Oral Product
1155143SCDG -
Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Liquid Product
2660259SCDGP -
Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Product
2663301SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Chlorpheniramine / pseudoephedrine Oral Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Chlorpheniramine maleate 0.4 MG/ML
996986SCDC -
Pseudoephedrine hydrochloride 6 MG/ML
995982SCDC
-
Chlorpheniramine maleate 0.4 MG/ML
Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Chlorpheniramine maleate 0.4 MG/ML
SCDC · 996986 -
Pseudoephedrine hydrochloride 6 MG/ML
SCDC · 995982 -
Chlorpheniramine / pseudoephedrine Oral Solution
SCDF · 371437 -
Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Solution
SCDFP · 2646526 -
Chlorpheniramine / pseudoephedrine Oral Liquid Product
SCDG · 1155142 -
Chlorpheniramine / pseudoephedrine Oral Product
SCDG · 1155143 -
Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Liquid Product
SCDGP · 2660259 -
Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Product
SCDGP · 2663301
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1053618 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 68047-0120-16 | 473 mL in 1 BOTTLE (68047-120-16) | LoHist D | Larken Laboratories, Inc. | 2003-09-15 |
Observed labelers:
Larken Laboratories, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.